[go: up one dir, main page]

FR2746313B1 - USE OF MELATONIN AND MELATONINERGIC LIGANDS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND DIABETIC COMPLICATIONS - Google Patents

USE OF MELATONIN AND MELATONINERGIC LIGANDS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND DIABETIC COMPLICATIONS

Info

Publication number
FR2746313B1
FR2746313B1 FR9603579A FR9603579A FR2746313B1 FR 2746313 B1 FR2746313 B1 FR 2746313B1 FR 9603579 A FR9603579 A FR 9603579A FR 9603579 A FR9603579 A FR 9603579A FR 2746313 B1 FR2746313 B1 FR 2746313B1
Authority
FR
France
Prior art keywords
melatonin
diabetes
prevention
treatment
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9603579A
Other languages
French (fr)
Other versions
FR2746313A1 (en
Inventor
Espiard Jean Guy Bizot
Philippe Delagrange
Lemaitre Beatrice Guardiola
Paul Michel Vanhoutte
Neto Jose Cipolla
Katsuya Nagai
Luc Penicaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Priority to FR9603579A priority Critical patent/FR2746313B1/en
Publication of FR2746313A1 publication Critical patent/FR2746313A1/en
Application granted granted Critical
Publication of FR2746313B1 publication Critical patent/FR2746313B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9603579A 1996-03-22 1996-03-22 USE OF MELATONIN AND MELATONINERGIC LIGANDS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND DIABETIC COMPLICATIONS Expired - Fee Related FR2746313B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9603579A FR2746313B1 (en) 1996-03-22 1996-03-22 USE OF MELATONIN AND MELATONINERGIC LIGANDS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND DIABETIC COMPLICATIONS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9603579A FR2746313B1 (en) 1996-03-22 1996-03-22 USE OF MELATONIN AND MELATONINERGIC LIGANDS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND DIABETIC COMPLICATIONS

Publications (2)

Publication Number Publication Date
FR2746313A1 FR2746313A1 (en) 1997-09-26
FR2746313B1 true FR2746313B1 (en) 1998-04-17

Family

ID=9490440

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9603579A Expired - Fee Related FR2746313B1 (en) 1996-03-22 1996-03-22 USE OF MELATONIN AND MELATONINERGIC LIGANDS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND DIABETIC COMPLICATIONS

Country Status (1)

Country Link
FR (1) FR2746313B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19823829A1 (en) * 1998-05-28 1999-12-02 Jenapharm Gmbh Pharmaceutical preparations for regulating insulin release by influencing the ß cell of the pancreatic islets
EP1667678B1 (en) 2003-10-03 2009-05-06 Veijlen N.V. Animal feed composition
CN1938018B (en) * 2003-10-03 2010-09-01 维伊林股份有限公司 Use of compounds for the preparation of compositions for the treatment of various disease states in humans and animals associated with reduced IGF-1 serum levels

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696453B1 (en) * 1992-10-02 1994-12-23 Adir New arylalkyl (thio) amides, process for their preparation, and pharmaceutical compositions containing them.
JPH09511334A (en) * 1994-03-30 1997-11-11 チバ−ガイギー アクチェンゲゼルシャフト Screening method using RZR receptor family

Also Published As

Publication number Publication date
FR2746313A1 (en) 1997-09-26

Similar Documents

Publication Publication Date Title
EP0906310A4 (en) OXADIAZOLE BENZENESULFONAMIDES AS AGONISTS -g (b) 3? SELECTIVE FOR THE TREATMENT OF DIABETES AND OBESITY
MA26790A1 (en) DIETETIC OR PHARMACEUTICAL COMPOSITION FOR USE IN THE PREVENTION OR TREATMENT OF HYPER-OXALURIA
FR2749759B1 (en) USE OF STRONTIUM SALTS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROSIS
AU4050797A (en) Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
EP0605024A3 (en) Use of purified surface modifiers to avoid aggregation of particles during sterilization.
FR2662354B1 (en) USE OF BACLOFENE FOR OBTAINING MEDICINAL PRODUCTS FOR THE TREATMENT OF ANGINA OF CHEST.
EP0635488A3 (en) Process for the preparation of azetidine compounds and precursor compounds therefor.
FR2742657B1 (en) COMPOSITIONS FOR THE TREATMENT OF KERATINIC MATERIALS COMPRISING THE ASSOCIATION OF A POLYAMPHOLYTE POLYMER AND A CATIONIC POLYMER
FR2628973B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN USE, AND PROCESS FOR THE PREPARATION OF SUCH A COMPOSITION
FR2712495B1 (en) Application of Óoenotheine B to obtain a medicament intended for the treatment of disorders linked to hyperandrogenism, and the pharmaceutical compositions containing it.
FR2717080B1 (en) Use of eipriprodil and its enantiomers for the preparation of medicaments useful in the treatment of peripheral neuropathies and central neurodegenerative diseases.
FR2746313B1 (en) USE OF MELATONIN AND MELATONINERGIC LIGANDS FOR THE PRODUCTION OF PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DIABETES AND DIABETIC COMPLICATIONS
FR2744361B1 (en) APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIES OR EXCESSIVE USE
FR2635461B1 (en) USE OF TRICYCLIC DERIVATIVES FOR OBTAINING MEDICINES FOR TREATING STRESS
FR2733685B1 (en) USE OF BENZOPYRANE DERIVATIVES FOR OBTAINING PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RELATED TO THE C1- / HC03-, NA + INDEPENDENT EXCHANGER
FR2758465B1 (en) COMPOSITION FOR THE TREATMENT OF ASBESTOS
FR2716623B1 (en) Use of a tricyclic derivative for obtaining medicaments intended for the treatment of mnemo-cognitive disorders.
DZ2564A1 (en) Pharmaceutical compositions for the treatment of diabetes mellitus and associated conditions.
EP0729938A3 (en) Process for the preparation of aryl-alkyl-hydroperoxides
FR2714603B1 (en) Dermatological composition and its use for the preparation of a medicament.
FR2759906B1 (en) USE OF MILNACIPRAN AND DERIVATIVES THEREOF FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF CERTAIN PSYCHIATRIC DISEASES
FR2795323B1 (en) USE OF MELATONINERGIC LIGANDS FOR OBTAINING PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF DISEASES OF THE GASTROINTESTINAL SYSTEM
FR2718024B1 (en) Medicine and pharmaceutical composition for the treatment of inflammation.
FR2737110B1 (en) USE OF MONOCARBOXYLIC ACIDS FOR THE TREATMENT OF KERATINIC MATERIALS
FR2744362B1 (en) APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIES OR EXCESSIVE USE

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse